Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Sustainable Products and Green Procurement Support

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

541620 - Environmental Consulting ServicesView NAICS

Place of Performance

WILLIAMSBURG, VA, 23185, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Advise on or supply products compliant with federal sustainability requirements such as energy efficiency and recyclable content.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJ
Solicitation # SPE2DP-26-T-4507
Sodium Chloride Injection in 10 mL single-dose syringes, preservative-free and latex-free, is being procured under contract SPE2DP-26-T-4507 with a total quantity of 4 pack groups, each containing 30 syringes, for a total of 120 units. The product must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging and labeling per Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each syringe must be sealed in a unit container that protects against damage and breakage, and all units must be packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest freight rate to the specified destination in Fort Campbell, Kentucky. The item is regulated by the FDA and requires referral through EBS for confirmation prior to award. The product has a fixed 24-month shelf-life from the date of manufacture, non-extendable, and must be clearly marked accordingly. Packaging must meet ASTM D3951 standards if the material is not classified as hazardous under FED-STD-313; otherwise, it must comply with TQ requirement IP025. The contract mandates shipment via traceable freight methods, excluding parcel post, with delivery required within 20 days of award. All packaging, marking, and palletization must adhere to RP001 DLA Packaging Requirements for Procurement. The supplier is AmerisourceBergen Drug Corp with part number 106346, and the item is identified by NSN 6505-01-595-5160. Delivery is FOB destination, with zero tolerance for quantity variance, and acceptance occurs at the point of delivery. The required delivery date is August 7, 2026.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
OATMEAL, COLLOIDAL CONC
Solicitation # SPE2DP-26-T-4504
The contract is for Oatmeal, Colloidal Concentrate, a medical supply regulated by the FDA, sourced under the Johnson & Johnson/NDC 81370-0364-00 specification. Each unit is packaged as 8 packets per PG unit, with a total requirement of 3 PG, equating to 24 individual packets. The item carries a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. Packaging must adhere to MIL-STD-2073-1E, ensuring sealed unit containers protect contents from damage during transport and are packed in commercially suitable exterior containers for safe, cost-effective delivery to the destination point. All markings and labeling must meet DLA medical standards, and copies of the marking guide are available via DLA Troop Support. The contract is issued under solicitation SPE2DP-26-T-4504 with a response deadline of August 11, 2026, and a delivery requirement of 20 days after award, FOB destination. The NSN is 6505-01-442-2051, and quantity variance is strictly zero percent with no tolerance for over or under delivery. Inspection and acceptance occur at the delivery point. The purchase request number is 7017749529, and pricing is set at a unit price of $3.00 per PG. The contracting official must submit a referral in EBS to confirm product compliance, including manufacturer and bidder details. The item falls under NAICS code 325412 and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA office. The delivery location is Fort Campbell, and all requirements are subject to DLA’s master list of technical and quality specifications as referenced by RP001 and RA001.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR IRRIGATIO
Solicitation # SPE2DP-26-T-4512
Water for Irrigation, Sterile, USP, is a 1000 mL sterile, distilled, and nonpyrogenic solution supplied in semi-rigid plastic containers with screw caps, intended exclusively for irrigation, washing, rinsing, and dilution purposes and not for injection by usual parenteral routes. Each package contains twelve units and is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, with a non-extendable shelf life of 36 months. Packaging and labeling must strictly adhere to the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging in compliance with ASTM D3951 unless otherwise specified by DLA’s Master List of Technical and Quality Requirements, which take precedence. All shipments are to be delivered FOB destination within five days, with zero variance allowed in quantity, and are subject to inspection and acceptance at the delivery point. The item is regulated by the FDA, and contractor submissions require referral through EBS for confirmation. Delivery is directed to multiple U.S. Navy vessels across FPO addresses, with specific shipment instructions prohibiting parcel post and requiring traceable transport methods. Palletization and packaging follow DLA’s RP001 requirements, and each order line item is tied to unique contract line item numbers, purchase requests, and delivery schedules ranging from March through August 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
MOXIFLOXACIN HYDROCHLO
Solicitation # SPE2DP-26-T-4509
Moxifloxacin Hydrochloride Tablets, 400 mg in 30-tablet bottles, are being procured under solicitation SPE2DP-26-T-4509 with a total quantity of 8 bottles, each containing 30 tablets, for delivery within 20 days FOB destination. The item is regulated by the FDA and must comply with the Medical Marking Standard No. 1 dated February 4, 2013, which supersedes all references to MIL-STD-129. Packaging must meet commercial standards as specified in the procurement document, with each unit sealed in a container that protects against damage or breakage and packed in suitable exterior shipping containers to ensure safe delivery at the lowest carrier rate. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature, avoiding high humidity. Accepted manufacturers include TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC., with designated NDC numbers. The contract requires strict adherence to DLA’s Master List of Technical and Quality Requirements, and any covered defense information must be marked in accordance with the latest edition of Medical Marking Standard No. 1. Inspection and acceptance occur at the destination with zero variance permitted in quantity. A referral must be sent via EBS to the product specialist confirming bidder, manufacturer, and product details prior to award.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR INJECTION, ST
Solicitation # SPE2DP-26-T-4510
Water for Injection, Sterile, USP, is procured in 20ml vials with flip-top closures, packaged in units of 25 vials per package, with a non-extendable shelf life of 24 months. The product must be stored at controlled room temperature between 20–25°C (68–77°F) and marked in accordance with the latest edition of the Medical Marking Standard No. 1. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with compliance determined by the revision in effect on the solicitation or award date, depending on acquisition size. The item is regulated by the FDA and requires a referral through EBS to confirm bidder and manufacturer details, including NDC numbers for Hospira Worldwide LLC (NDC 00409-4887-20) and Fresenius Kabi, LLC (NDC 63323-0185-20). The NSN is 6505005825079, with a single package quantity of one unit. Delivery is required within 20 days to Fort Campbell, Kentucky, FOB destination, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from non-accepted supplies. The solicitation is issued under SPE2DP-26-T-4510, with a response deadline of August 11, 2026, and is classified under NAICS code 325412 by the Department of Defense’s Medical Supply Chain PHARM FSA.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
LEVONORGESTREL AND ETH
Solicitation # SPE2DP-26-T-4515
The contract specifies the procurement of LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP, a hormonal contraceptive product regulated by the FDA, supplied by TEVA PHARMACEUTICALS USA, INC. Each package contains 168 tablets organized into six cycles of 28 tablets each, with a controlled sequence of active and inert tablets: six tablets with 50 mcg levonorgestrel and 30 mcg ethinyl estradiol, followed by five tablets with 75 mcg levonorgestrel and 40 mcg ethinyl estradiol, ten tablets with 125 mcg levonorgestrel and 30 mcg ethinyl estradiol, and seven inert tablets. The unit of issue is one package (PG) equaling 168 tablets, with a total order of two packages. The product must have a minimum of 21 months of remaining shelf life at the time of receipt by the first government activity, with a full 24-month shelf life from manufacture. Storage must be maintained at controlled room temperature between 20°C and 25°C (68°F to 77°F). Packaging and labeling must comply strictly with Medical Marking Standard No. 1A dated February 4, 2013, replacing all references to MIL-STD-129, and all units must be sealed in commercial containers that protect against damage and ensure safe, cost-effective delivery to Fort Campbell, TN, with delivery required within 20 days. The product is subject to federal acquisition regulations and requires pre-award confirmation through the EBS referral system, including manufacturer and product identification. The NSN is 6505012240176, the solicitation number is SPE2DP-26-T-4515, and the contract is awarded under a no-variance quantity agreement with FOB destination terms.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ENROFLOXACIN INJECT
Solicitation # SPE2DP-26-T-4496
Enrofloxacin Injection, a veterinary antibiotic solution for dogs, is supplied at a concentration of 2.27% with a dosage of 2.5 mg per kilogram in a 20 mL volume, intended for intramuscular use in managing bacterial pathogens. The product is regulated by the FDA and requires strict adherence to shelf-life requirements, with a non-extendable shelf life of 24 months classified as a Type I (Code M) item. Storage must be maintained at or below 25 degrees Celsius with excursions permitted up to 40 degrees Celsius, and the product must be protected from direct sunlight and freezing. Packaging and marking must conform to the latest edition of the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage and ensure safe transport. The item is procured under contract SPE2DP-26-T-4496 with a single unit of issue, delivered FOB destination within 81 days, with zero variance tolerance. Delivery is directed to the U.S. Medical Material Center in Kaiserslautern, Germany, with the required delivery date set for August 5, 2026. Supplier information includes Patterson Veterinary Supply, Inc. and Covetrus North America, LLC with designated part numbers, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements. The contracting official must submit a referral via EBS for FDA-regulated product confirmation prior to award, including manufacturer and bidder details.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details